Dr Ikram Ulhaq Qureshi, MD is a
Internal Medicine physician based in Bonifay, Florida. Dr Ikram Ulhaq Qureshi is licensed to practice in Florida (license number ME23207) and his current practice location is 812 S Weeks St, Bonifay, Florida. He can be reached at his office (for appointments etc.) via phone at
(850) 547-4771.
NPI number for Dr Ikram Ulhaq Qureshi is 1295765550 and his current mailing address is 812 S Weeks St, Bonifay, Florida. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1295765550.
Physician's Profile
| Full Name | Dr Ikram Ulhaq Qureshi |
|---|
| Gender | Male |
|---|
| Speciality | Internal Medicine |
|---|
| Location | 812 S Weeks St, Bonifay, Florida |
|---|
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1295765550
- Provider Enumeration Date: 07/03/2006
- Last Update Date: 12/09/2011
Medical Identifiers
Medical identifiers for Dr Ikram Ulhaq Qureshi such as npi, medicare ID, medicare PIN, medicaid, etc.
| Identifier | Type | State | Issuer |
| 1295765550 | NPI | - | NPPES |
| 592768062 | Other | | TAX ID |
| 039448300 | Medicaid | FL | |
Medical Taxonomies and Licenses
| Taxonomy | Type | License (State) | Status |
| 207R00000X | Internal Medicine | ME23207 (Florida) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Ikram Ulhaq Qureshi is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
| Mailing Address | Practice Location Address |
Dr Ikram Ulhaq Qureshi, MD 812 S Weeks St, Bonifay, FL 32425-3047 Ph: (850) 547-4771 | Dr Ikram Ulhaq Qureshi, MD 812 S Weeks St, Bonifay, FL 32425-3047 Ph: (850) 547-4771 |
Reviews and Comments